LK-44
HCES2A-IN-2 (Compound 44) is an orally active human carboxylesterase 2 (hCES2A) inhibitor (IC50: 5.02 μM). hCES2A-IN-2 improves Irinotecan -induced delayed diarrhea[1].
Product Specifications
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lk-44.html
Solubility
10 mM in DMSO
Smiles
CCCOC1=CC=C(C(/C(O2)=C/C3=CC(Cl)=C(OC(C)(C)C(O)=O)C=C3)=O)C2=C1
Molecular Formula
C22H21ClO6
Molecular Weight
416.85
References & Citations
[1]Yang Z, et al. Design, synthesis, and biological evaluation studies of novel carboxylesterase 2 inhibitors for the treatment of irinotecan-induced delayed diarrhea. Bioorg Chem. 2023 Sep;138:106625.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1143868-01 0.05 mg (E-Coli)
Recombinant Human Frizzled-7 (FZD7), partial
Sign In for Pricing
View Details MBS1143868-02 0.2 mg (Yeast)
Recombinant Human Frizzled-7 (FZD7), partial
Sign In for Pricing
View Details MBS1143868-03 0.5 mg (Yeast)
Recombinant Human Frizzled-7 (FZD7), partial
Sign In for Pricing
View Details MBS1143868-04 1 mg (Yeast)
Recombinant Human Frizzled-7 (FZD7), partial
Sign In for Pricing
View Details